cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-02

AUTHORS

Franca Morazzoni, Carmen Canevali, Massimo Zucchetti, Sergio Caroli, Alessandro Alimonti, Francesco Petrucci, Gabriella Giudice, Enrico Masoni, Amedeo Vittorio Bedini

ABSTRACT

The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein. More... »

PAGES

37-43

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004320050131

DOI

http://dx.doi.org/10.1007/s004320050131

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046233188

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9498833


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0202", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Atomic, Molecular, Nuclear, Particle and Plasma Physics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morazzoni", 
        "givenName": "Franca", 
        "id": "sg:person.01255100453.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255100453.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Canevali", 
        "givenName": "Carmen", 
        "id": "sg:person.0751665324.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751665324.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mario Negri Institute for Pharmacological Research", 
          "id": "https://www.grid.ac/institutes/grid.4527.4", 
          "name": [
            "Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Via Eritrea 62, 20157 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zucchetti", 
        "givenName": "Massimo", 
        "id": "sg:person.0720105551.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720105551.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caroli", 
        "givenName": "Sergio", 
        "id": "sg:person.01067474735.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067474735.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alimonti", 
        "givenName": "Alessandro", 
        "id": "sg:person.01247677103.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247677103.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrucci", 
        "givenName": "Francesco", 
        "id": "sg:person.01065335303.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065335303.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giudice", 
        "givenName": "Gabriella", 
        "id": "sg:person.0652707500.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652707500.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masoni", 
        "givenName": "Enrico", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bedini", 
        "givenName": "Amedeo Vittorio", 
        "id": "sg:person.01035226740.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035226740.01"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-02", 
    "datePublishedReg": "1998-02-01", 
    "description": "The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s004320050131", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "124"
      }
    ], 
    "name": "cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach", 
    "pagination": "37-43", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "dc3b90a570e3483c7f006a30fbc3139798e01be9da5d4ea55e88ea7571002cbb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9498833"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004320050131"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046233188"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004320050131", 
      "https://app.dimensions.ai/details/publication/pub.1046233188"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s004320050131"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      20 PREDICATES      40 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004320050131 schema:about N060627059da4473a8a5d6787e2f188b4
2 N1bba45434157401ea47045b9deef6829
3 N2218930556a04b639769a7fedde20047
4 N457c0fcea8014d8bacbfb0c8b9c5d94a
5 N5535d7544be241e9928e1c233e59d5e9
6 N6cc9bb7937d04cdfaee16e2b3412dcfc
7 N70bab97421ca4ccda179e81c67207926
8 N741a2749907e433882f4ecb56bd81ef0
9 N88ab1ea9dd9c4e65ab40f2efc87fc426
10 Nf4b2d810c4ab41bcbce94fa43a05d86f
11 Nfa107eaa6e0f4df4b9afaa4edb6e8c9c
12 anzsrc-for:02
13 anzsrc-for:0202
14 schema:author N34681b3f764043d3b163033630837bb9
15 schema:datePublished 1998-02
16 schema:datePublishedReg 1998-02-01
17 schema:description The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N44cbd49cdd5042afbadb46bd15f2767f
22 Ndc92b3a98fd64dc7a3ca5bcb91f41b7b
23 sg:journal.1313647
24 schema:name cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach
25 schema:pagination 37-43
26 schema:productId N0e5dc9074acd4b89b45c4a72555dcc9f
27 N2f61435e0c4a41a18b4863b5e3b6b7d0
28 N83802d3d9c714533804b649adb681683
29 Nc3b28b6f11884f26b6929fec432fe245
30 Nf2010898c7be4a7cb4cf29e41186545b
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046233188
32 https://doi.org/10.1007/s004320050131
33 schema:sdDatePublished 2019-04-10T21:32
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher N7aee92217e1c4309a91bcb074065e6c5
36 schema:url http://link.springer.com/10.1007/s004320050131
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N060627059da4473a8a5d6787e2f188b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
41 schema:name Combined Modality Therapy
42 rdf:type schema:DefinedTerm
43 N0e5dc9074acd4b89b45c4a72555dcc9f schema:name pubmed_id
44 schema:value 9498833
45 rdf:type schema:PropertyValue
46 N15564a48eb0947d79a8c59f42ef41a57 rdf:first sg:person.01065335303.03
47 rdf:rest Nc3a45fd114e34b4db50b4c5f64f836ec
48 N1bba45434157401ea47045b9deef6829 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Carcinoma, Non-Small-Cell Lung
50 rdf:type schema:DefinedTerm
51 N2218930556a04b639769a7fedde20047 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Adult
53 rdf:type schema:DefinedTerm
54 N2f61435e0c4a41a18b4863b5e3b6b7d0 schema:name nlm_unique_id
55 schema:value 7902060
56 rdf:type schema:PropertyValue
57 N34681b3f764043d3b163033630837bb9 rdf:first sg:person.01255100453.07
58 rdf:rest Ne09a292d07ff4bd381730a12a93a475e
59 N42960a27a73d46678d09ce9afcbcae53 rdf:first sg:person.01035226740.01
60 rdf:rest rdf:nil
61 N44cbd49cdd5042afbadb46bd15f2767f schema:volumeNumber 124
62 rdf:type schema:PublicationVolume
63 N457c0fcea8014d8bacbfb0c8b9c5d94a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Lung Neoplasms
65 rdf:type schema:DefinedTerm
66 N5535d7544be241e9928e1c233e59d5e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Humans
68 rdf:type schema:DefinedTerm
69 N5ea869de01da4f30bedce878c9bd614d schema:affiliation https://www.grid.ac/institutes/grid.4708.b
70 schema:familyName Masoni
71 schema:givenName Enrico
72 rdf:type schema:Person
73 N6cc9bb7937d04cdfaee16e2b3412dcfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Female
75 rdf:type schema:DefinedTerm
76 N70bab97421ca4ccda179e81c67207926 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Aged
78 rdf:type schema:DefinedTerm
79 N71ca3d5fbdf14e518a4b9c74974912e8 rdf:first N5ea869de01da4f30bedce878c9bd614d
80 rdf:rest N42960a27a73d46678d09ce9afcbcae53
81 N741a2749907e433882f4ecb56bd81ef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Male
83 rdf:type schema:DefinedTerm
84 N7a4464ae2310414a89962fa5620fc991 rdf:first sg:person.01247677103.36
85 rdf:rest N15564a48eb0947d79a8c59f42ef41a57
86 N7aee92217e1c4309a91bcb074065e6c5 schema:name Springer Nature - SN SciGraph project
87 rdf:type schema:Organization
88 N83802d3d9c714533804b649adb681683 schema:name doi
89 schema:value 10.1007/s004320050131
90 rdf:type schema:PropertyValue
91 N88ab1ea9dd9c4e65ab40f2efc87fc426 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Middle Aged
93 rdf:type schema:DefinedTerm
94 Nc3a45fd114e34b4db50b4c5f64f836ec rdf:first sg:person.0652707500.73
95 rdf:rest N71ca3d5fbdf14e518a4b9c74974912e8
96 Nc3b28b6f11884f26b6929fec432fe245 schema:name readcube_id
97 schema:value dc3b90a570e3483c7f006a30fbc3139798e01be9da5d4ea55e88ea7571002cbb
98 rdf:type schema:PropertyValue
99 Nd5bc363e60ac42c3bd138210b64ad3e4 rdf:first sg:person.0720105551.12
100 rdf:rest Nf33c045b2e3f436c879b0fe8550d1f5f
101 Ndc92b3a98fd64dc7a3ca5bcb91f41b7b schema:issueNumber 1
102 rdf:type schema:PublicationIssue
103 Ne09a292d07ff4bd381730a12a93a475e rdf:first sg:person.0751665324.55
104 rdf:rest Nd5bc363e60ac42c3bd138210b64ad3e4
105 Nf2010898c7be4a7cb4cf29e41186545b schema:name dimensions_id
106 schema:value pub.1046233188
107 rdf:type schema:PropertyValue
108 Nf33c045b2e3f436c879b0fe8550d1f5f rdf:first sg:person.01067474735.12
109 rdf:rest N7a4464ae2310414a89962fa5620fc991
110 Nf4b2d810c4ab41bcbce94fa43a05d86f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Cisplatin
112 rdf:type schema:DefinedTerm
113 Nfa107eaa6e0f4df4b9afaa4edb6e8c9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Antineoplastic Agents
115 rdf:type schema:DefinedTerm
116 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
117 schema:name Physical Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:0202 schema:inDefinedTermSet anzsrc-for:
120 schema:name Atomic, Molecular, Nuclear, Particle and Plasma Physics
121 rdf:type schema:DefinedTerm
122 sg:journal.1313647 schema:issn 0171-5216
123 1432-1335
124 schema:name Journal of Cancer Research and Clinical Oncology
125 rdf:type schema:Periodical
126 sg:person.01035226740.01 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
127 schema:familyName Bedini
128 schema:givenName Amedeo Vittorio
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035226740.01
130 rdf:type schema:Person
131 sg:person.01065335303.03 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
132 schema:familyName Petrucci
133 schema:givenName Francesco
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065335303.03
135 rdf:type schema:Person
136 sg:person.01067474735.12 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
137 schema:familyName Caroli
138 schema:givenName Sergio
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067474735.12
140 rdf:type schema:Person
141 sg:person.01247677103.36 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
142 schema:familyName Alimonti
143 schema:givenName Alessandro
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247677103.36
145 rdf:type schema:Person
146 sg:person.01255100453.07 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
147 schema:familyName Morazzoni
148 schema:givenName Franca
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255100453.07
150 rdf:type schema:Person
151 sg:person.0652707500.73 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
152 schema:familyName Giudice
153 schema:givenName Gabriella
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652707500.73
155 rdf:type schema:Person
156 sg:person.0720105551.12 schema:affiliation https://www.grid.ac/institutes/grid.4527.4
157 schema:familyName Zucchetti
158 schema:givenName Massimo
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720105551.12
160 rdf:type schema:Person
161 sg:person.0751665324.55 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
162 schema:familyName Canevali
163 schema:givenName Carmen
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751665324.55
165 rdf:type schema:Person
166 https://www.grid.ac/institutes/grid.416651.1 schema:alternateName Istituto Superiore di Sanità
167 schema:name Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy, IT
168 rdf:type schema:Organization
169 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
170 schema:name Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT
171 rdf:type schema:Organization
172 https://www.grid.ac/institutes/grid.4527.4 schema:alternateName Mario Negri Institute for Pharmacological Research
173 schema:name Istituto di Ricerche Farmacologiche “Mario Negri”, Via Eritrea 62, 20157 Milano, Italy, IT
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.4708.b schema:alternateName University of Milan
176 schema:name Dipartimento di Scienza dei Materiali, Università di Milano, Via Emanueli 15, 20126 Milano, Italy, IT
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...